Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common reasons of enzyme increase in liver. In About 10 percent of patients with NAFLD, the disease progresses toward Non Alcoholic Steatohepatitis (NASH) and about one third of them may progress toward cirrhosis, liver dysfunct...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajiaghamohammadi, Ali Akbar, Ziaee, Amir, Oveisi, Sonia, Masroor, Homa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475019/
https://www.ncbi.nlm.nih.gov/pubmed/23087748
http://dx.doi.org/10.5812/hepatmon.6099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475019/
https://www.ncbi.nlm.nih.gov/pubmed/23087748
http://dx.doi.org/10.5812/hepatmon.6099

Ejemplares similares